๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085
NCT07412353Healthy Participants
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
74
Shanghai
2026-01-12
Recruiting
IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
NCT07376603Nasopharyngeal Cancinoma (NPC), Intensity-modulated Radiotherapy, Stage IB
Qiaojuan Guo
Observational
169
Fuzhou
2026-01-12
Recruiting
Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery
NCT07332806Robotic Surgical Procedures, Airway Extubation, Operating Rooms, Anesthesia Recovery Period
Peking University First Hospital
Not applicable
218
Beijing
2026-01-12
Recruiting
Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
NCT07349160Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
36
Beijing
2026-01-10
Recruiting
The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted Therapy
NCT07376174Breast Cancer, HER2/CEP17 Ratio
Shandong Cancer Hospital and Institute
Observational
300
Jinan
2026-01-10
Not yet open
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma๏ผˆLB2505-0001๏ผ‰
NCT07399444Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1
38
Zhengzhou, Wuhan, Xuzhou, Nanchang, Beijing, Tianjin
2026-01-10
Recruiting
Fucoidan in the Treatment of Active Rheumatoid Arthritis
NCT07045896Arthritis, Rheumatoid
Peking University People's Hospital
Not applicable
40
Beijing
2026-01-10
Not yet open
Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents
NCT07339956Gastrointestinal Bleeding
China-Japan Friendship Hospital
Phase EARLY_PHASE1
60
Beijing
2026-01-10
Recruiting
A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA
NCT07362667ABPA, Allergic Bronchopulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA), Airway Clearance
Qianfoshan Hospital
Observational
44
Jinan
2026-01-10
Not yet open
Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma
NCT07356037Cachexia, Hepatocellular Carcinoma
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
68
Chengdu
2026-01-10
Recruiting
Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer
NCT07410975NSCLC Stage II, NSCLC Stage III
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
54
Shanghai
2026-01-10
Recruiting
Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients
NCT07820254Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Shanghai Pulmonary Hospital, Shanghai, China
Observational
60
Shanghai
2026-01-10
Active, closed
A Study of SYH2069 Injection in Healthy Participants
NCT07736391Overweight or Obesity, Diabetes
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1
104
Nanjing
2026-01-10
Active, closed
Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia
NCT07733037Immune Thrombocytopenia (ITP)
Peking University People's Hospital
Phase 2
42
Beijing
2026-01-10
Not yet open
Osteoporotic Vertebral Compression Fracture Cohort Study
NCT07321795OVCF Database, Cohort Study
Wangjing Hospital, China Academy of Chinese Medical Sciences
Observational
200
Hunan, Suzhou, Weihai, Beijing
2026-01-10
Not yet open
Biomechanical Study of Lever Positioning Manipulation on Scoliosis
NCT07325045Scoliosis
The Third Affiliated hospital of Zhejiang Chinese Medical University
Not applicable
30
Zhejiang
2026-01-10
Recruiting
Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis
NCT07242768Ischemic Stroke, Transient Ischemic Attack
Capital Medical University
Observational
1,300
Beijing
2026-01-10
Recruiting
Diagnostic Biomarkers for Checkpoint Inhibitor-related Pneumonitis
NCT07340892Checkpoint Inhibitor-related Pneumonitis
Zhou Chengzhi
Observational
60
Guangzhou
2026-01-10
Not yet open
Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma
NCT07394244Cutaneous Squamous Cell Carcinoma (CSCC)
Fudan University
Phase 2
38
Shanghai
2026-01-09
Recruiting
International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT07013461Nasopharyngeal Cancinoma (NPC)
The University of Hong Kong-Shenzhen Hospital
Observational
5,000
Shenzhen
2026-01-09
Recruiting
Bioequivalence Study of GZR18 Injection Before and After CMC Change
NCT07355738Obesity&T2D
Gan & Lee Pharmaceuticals.
Phase 1
138
Suzhou
2026-01-09
Active, closed
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
NCT07321951Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
201
Guangzhou, Hangzhou
2026-01-09
Recruiting
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
NCT07262476Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
258
Shanghai
2026-01-09
Active, closed
LishitonglinUS-01 Trial
NCT07769060Urethra Stricture
Peking University First Hospital
Phase 2
120
Beijing
2026-01-09
Recruiting
Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
NCT07347860Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
12
Wuhan
2026-01-08
Recruiting
A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors
NCT07131202Advanced Solid Tumors
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
130
Guangzhou
2026-01-08
Recruiting
An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors
NCT07359066Advanced Solid Tumors, PARP Inhibitor
Shanghai SciBrunch Therapeutics Co., Ltd.
Phase 1/2
210
Beijing, Harbin
2026-01-08
Recruiting
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
NCT07388602Amyloidosis
Sinocelltech Ltd.
Phase 3
90
Beijing
2026-01-08
Recruiting
Effects of Short-term Intensive Statin Therapy on Lipid Levels
NCT07344610Ischemic Stroke
General Hospital of Shenyang Military Region
Observational
800
Shenyang
2026-01-08
Recruiting
7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy
NCT07232095Helicobacter Pylori
The First Affiliated Hospital with Nanjing Medical University
Phase 4
316
Nanjing
2026-01-08
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285Overweight, Obesity
Novo Nordisk A/S
Phase 3
460
Beijing, Zhengzhou, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2026-01-08
By invitation
AI-based Prediction of Prostate Cancer Metastasis Using Biopsy Pathology
NCT07660276Prostate Cancer Metastatic
Xiangya Hospital of Central South University
Observational
3,000
Changsha
2026-01-08
Recruiting
Liposomal Irinotecan Plus 5-FU/LV and Sintilimab With Sequential SBRT for Locally Advanced Biliary Tract Cancer
NCT07797816Biliary Tract Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
31
Nanjing
2026-01-08
Recruiting
A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
NCT07275788Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Regend Therapeutics
Phase 1
15
Shanghai
2026-01-08
Recruiting
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
NCT07296341Locally Advanced or Metastatic Pancreatic Cancer With
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
60
Beijing
2026-01-08
Recruiting
Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis
NCT07324785Diabetic Gastroparesis
Northern Jiangsu People's Hospital
Observational
50
Yangzhou
2026-01-07
Recruiting
A Study๏ผˆPhase I๏ผ‰of GS3-007a Dry Suspension in Healthy Chinese Adults
NCT07473570Healthy Adults
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
32
Shanghai
2026-01-07
Recruiting
A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD)
NCT07487311Inflamatory Bowel Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
80
Hangzhou
2026-01-07
Recruiting
Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia
NCT07311343Hemorrhage, Pneumonia
Beijing Tiantan Hospital
Phase 4
440
Beijing
2026-01-07
Recruiting
Photon-Counting Cardiac CT in Post-PCI Patients
NCT07763340Cardiovascular Diseases
Chinese PLA General Hospital
Observational
800
Beijing
2026-01-07
Recruiting
An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma
NCT07344818R/R Aggressive B-cell Lymphoma
Peking University People's Hospital
Phase EARLY_PHASE1
18
Beijing
2026-01-07
Recruiting
Photon-counting CT for Intracranial Stent Assessment
NCT07769814Intracranial Atherosclerotic Disease (ICAD), Intracranial Arterial Stenosis, Stent Restenosis, Ischemic Stroke
Xin Lou
Observational
200
Beijing
2026-01-07
Recruiting
the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
NCT07380646Leucogen, Ribociclib, Neutropenia (Low White Blood Cell Count), Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
94
Hangzhou
2026-01-07
Recruiting
The Optimal Measurement Time for the New Gallbladder Function Assessment Method
NCT07321431Gallbladder; Functional Disturbance
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
120
Lanzhou, Qinhuangdao, Shenyang, Yinchuan, Xiโ€™an
2026-01-07
Recruiting
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patients With Carotid Artery Stenosis
NCT07762664Carotid Artery Stenosis, Carotid Atherosclerosis, Carotid Atherosclerotic Plaque
Chinese PLA General Hospital
Observational
100
Beijing
2026-01-07
Recruiting
This Prospective Observational Study Aims to Evaluate the Capability of Ultra-high-resolution Photon-counting CT Angiography (UHR PCD-CTA) for Noninvasive Evaluation of Intracranial Venous Sinus Stents. The Study Will Compare Image Quality, Stent Visualization, Metal-related Artifacts, and Diagnosti
NCT07762677Intracranial Stenosis, Venous Sinus Stenosis, Stent Implantation, Intracranial Venous Pressures
Xin Lou
Observational
200
Beijing
2026-01-07
Not yet open
Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMR
NCT07294495HCM - Hypertrophic Cardiomyopathy
Shanghai East Hospital
Not applicable
150
Shanghai
2026-01-07
Recruiting
Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR
NCT07371273Colorectal Cancer
Fudan University
Phase 2
100
Shanghai
2026-01-07
Not yet open
Phase โ…ก Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
NCT07327398Influenza
Shanghai Institute Of Biological Products
Phase 2
1,200
Wuhan
2026-01-07
Recruiting
IBI363 (PD-1/IL-2ฮฑ-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer
NCT07408635Unresectable Stage III Non-small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
43
Shanghai
2026-01-07
Recruiting
A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors
NCT07298772Advanced Solid Tumor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
198
Shanghai
2026-01-07
Recruiting
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion
NCT07185022Stroke, Cerebrovascular Disorders, Brain Diseases, Nervous System Diseases
The Second Hospital of Anhui Medical University
Not applicable
282
Fuyang, Hefei, Lu'an, Liuzhou, Lishui
2026-01-06
Recruiting
Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children
NCT07318831Neuroblastoma (NB), Neuroblastoma in Children
Tianjin Medical University Cancer Institute and Hospital
Phase 2
27
Tianjin
2026-01-06
Active, closed
MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer
NCT07692230HR Positive/HER-2 Negative Breast Cancer
Fudan University
Observational
2,000
Shanghai
2026-01-06
Recruiting
Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Thoracoscopic Lung Resection
NCT07018375Chronic Postsurgical Pain
Tianjin Medical University General Hospital
Phase 4
320
Baoding, Tangshan, Tianjin
2026-01-06
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Huizhou, Jiangmen, Nanning
2026-01-06
Recruiting
Effects of NR Supplementation on Metabolic Flexibility in Zone 2 Training
NCT07344636Health Adult Subjects
ZHANG Jiaqi
Not applicable
16
Hong Kong
2026-01-06
Recruiting
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
NCT07400003Herpes Zoster, mRNA Vaccine
Sinovac Biotech Co., Ltd
Phase 1/2
519
Xinjiang
2026-01-06
Recruiting
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study
NCT07454070Depressive Disorder (Per DSM-V Criteria, Mild-to-moderate), Acute Coronary Syndrome (ACS), Percutaneous Coronary Intervention (PCI), Depressive Disorder
Jing Han
Not applicable
120
Xi'an
2026-01-06
Recruiting
Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy
NCT07293338Dilated Cardiomyopathy (DCM)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
330
Hangzhou
2026-01-06
Recruiting
Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom
NCT07239596Advanced Renal Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
92
Beijing
2026-01-06
Recruiting
Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
NCT07253181Acute Ischemic Stroke, Large Vessel Occlusion, Transportation of Patients
Xuanwu Hospital, Beijing
Phase 3
572
Beijing, Weifang
2026-01-06
Recruiting
A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China
NCT07821957Intracranial Aneurysm
Beijing Tiantan Hospital
Not applicable
280
Beijing
2026-01-06
Recruiting
Pregnancy Salt Substitution Trial for Hypertensive Disorders of Pregnancy Prevention (PREG-Salt)
NCT07294807Hypertensive Disorders of Pregnancy
Peking University
Not applicable
3,200
Bishan, Fuling, Gunan, Hechuan, Jiangjin, Qianjiang, Shapingba, Wulong
2026-01-06
Not yet open
Phase I Study of FXS887 in the Treatment of Solid Tumors
NCT07345637Solid Tumor Refractory to Conventional Treatment
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
14
Shanghai
2026-01-05
Recruiting
Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery
NCT07308756General Anesthesia, Surgery, Dexmedetomidine, Esketamine
Peking University First Hospital
Phase 4
316
Beijing
2026-01-05
Recruiting
Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL
NCT07441993Marginal Zone Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
30
Guangzhou, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanjing, Nantong, Nanchang
2026-01-05
Not yet open
A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer
NCT07235618Locally Advanced or Metastatic Breast Cancer
Sun Yat-sen University
Phase 2
50
Guangzhou
2026-01-05
Recruiting
A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy
NCT07289477Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
iRegene Therapeutics Co., Ltd.
Phase 1
9
Beijing
2026-01-05
Active, closed
Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression
NCT07585877Myopia Progressing, Myopia
Zhongda Hospital
Not applicable
104
Nanjing
2026-01-05
Recruiting
A Clinical Trial of P134 Cells in Recurrent Glioblastoma
NCT07318818Recurrent Glioblastoma IDH Wildtype
Tasly Pharmaceutical Group Co., Ltd
Phase 1/2
26
Beijing
2026-01-05
Recruiting
Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
NCT07333274Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer
Shandong Cancer Hospital and Institute
Phase 3
335
Shandong
2026-01-05
Recruiting
Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line
NCT07501351Hepatocellulcar Carcinoma
Sun Yat-sen University
Phase 2
80
Guangzhou
2026-01-05
Recruiting
Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
NCT07435701Ovarian Neoplasms Malignant, Ascites
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
29
Beijing
2026-01-05
Recruiting
An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
NCT07357610Healthy Adult Participants
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
60
Jinan
2026-01-05
Recruiting
A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
NCT07280936Obesity, Overweight
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 1
124
Hangzhou
2026-01-05
Recruiting
Hemoadsorption for Severe Ischemic Stroke
NCT07127484Ischemic Stroke, Hemoadsorption
First Affiliated Hospital of Wannan Medical College
Not applicable
116
Wuhu
2026-01-05
Recruiting
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
NCT07354711Lung Cancer, Stomach Cancer
3H Pharmaceuticals Co., Ltd.
Phase 1/2
170
Beijing
2026-01-04
Recruiting
Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer
NCT07457359TNBC, Triple Negative Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
18
Hangzhou
2026-01-04
Recruiting
Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma
NCT07511725Glioblastoma (GBM)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Hangzhou
2026-01-04
Not yet open
Drug-drug Interaction Study of Rifampin and Anaprazole Sodium
NCT07330531Drug-drug Interaction Study
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 4
24
Jinan
2026-01-04
Recruiting
Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers
NCT07302269Healthy Volunteers
Vigonvita Life Sciences
Phase 1
58
Hefei
2026-01-04
Active, closed
SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a)
NCT07745114Healthy Participants, Elevated Lp(a)
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 1
144
Hefei
2026-01-04
Recruiting
High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS
NCT07298889Noninvasive Ventilation, Pneumonia, ARDS
Chongqing Medical University
Not applicable
706
Chongqing
2026-01-04
Recruiting
An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC
NCT07452003Non-Small Cell Lung Cancer
Peking Union Medical College Hospital
Not applicable
30
Beijing
2026-01-03
Recruiting
Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRI
NCT07755670Hidradenitis Suppurativa (HS)
Second Xiangya Hospital of Central South University
Observational
80
Changsha
2026-01-03
Recruiting
Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis
NCT07388420Hypertriglyceridemia Induced Acute Pancreatitis
General Hospital of Shenyang Military Region
Not applicable
40
Shenyang
2026-01-02
Recruiting
Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery
NCT07315828Giant Cell Tumor of Bone
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase 4
40
Shanghai
2026-01-02
Recruiting
An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children
NCT07354945Myopia, Refractive Error
Essilor International
Not applicable
40
Shanghai
2026-01-02
Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
NCT07063745Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Bristol-Myers Squibb
Phase 2/3
590
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shenzhen, Nanning
2026-01-02
Recruiting
KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
NCT07246707B-ALL
Zhejiang University
Phase 1
30
Hangzhou
2026-01-02
Recruiting
Pulsatile Electrical Impedance Tomography for Diagnosis and Monitoring of Acute Pulmonary Embolism
NCT07724197Pulmonary Embolism Acute
Beijing Tsinghua Chang Gung Hospital
Observational
275
Beijing, Chenzhou, Loudi
2026-01-02
Recruiting
Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery
NCT07315841Tenosynovial Giant Cell Tumor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase 4
40
Shanghai
2026-01-02
Not yet open
Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program
NCT07129369Psychotic Disorders, Recent-Onset Psychosis
Chinese University of Hong Kong
Not applicable
186
Hong Kong
2026-01-02
Not yet open
Epicardial Adipose Tissue-Targeted DApagliflozin for Reducing Electrical Remodeling in Atrial Fibrillation
NCT07331727Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
280
Shanghai
2026-01-01
Active, closed
Construction and Validation of an Intelligent Ultrasound Diagnostic System for the Spectrum of Neuroblastoma in Children
NCT07549425Neuroblastic Tumors
The Children's Hospital of Zhejiang University School of Medicine
Observational
300
Hefei, Suzhou, Kunming, Hangzhou, Wenling
2026-01-01
Active, closed
Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction Cancer
NCT07429318Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing
2026-01-01
Not yet open
Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors
NCT07282873Solid Tumor Malignancies, Malignant Mesothelioma (MM)
TYK Medicines, Inc
Phase 1/2
219
Shanghai
2026-01-01
Not yet open
ICSI Versus Conventional IVF in Couples With Unexplained Infertility
NCT07294027Unexplained Infertility
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
848
Beijing, Huangshi, Wuhan, Xiangyang, Hangzhou, Jiaxing, Ningbo
2026-01-01
Not yet open
A Prospective Multicenter Clinical Study on the Efficacy and Safety of the Zirconia Ceramic Hip Joint Prosthesis System After Its Market Launch
NCT07382050THA, Prosthesis
Peking University Third Hospital
Observational
290
Beijing
2026-01-01
Rows per page Showing 4301–4400 of 19052
Previous 42 43 44 45 46 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=44

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.